Clinical Trial

Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma

Name: Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma — clinical trial record (NCT07538206)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a prospective, single-arm, Phase II clinical trial designed to evaluate the efficacy and safety of vibecotamab combined with putelimab in the treatment of locally advanced laryngeal carcinoma.

Trial Details

NCT Number	NCT07538206
Lead Sponsor	Tang-Du Hospital
Conditions	Head & Neck Cancer
Enrollment	10 participants
Start Date	2026-04-23
Primary Completion	2031-04-23 (estimated)
Study Completion	2031-04-23 (estimated)
Updated on ClinicalTrials.gov	2026-04-20